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[etter  to  the  editor
etter on the article “Partial laryngectomy as
alvage surgery after radiotherapy: Oncological
nd functional outcomes and impact on quality
f life. A retrospective study of 20 cases”
irs,
I read with interest the recent paper by Philippe et al. [1] about
he treatment with partial laryngectomies of local recurrences in
reviously irradiated patients: as previously reported, when proper
election criteria for conservative salvage laryngeal surgery are
sed, laryngeal function can be preserved with oncological efﬁcacy
2].
However, considering that mistakes made (and perpetuated) in
eporting epidemiological data could have a determining inﬂuence
n international medical literature, I unfortunately have to point
ut that the authors signiﬁcantly over-estimated laryngeal carci-
oma prevalence stating that “laryngeal cancer is the ﬁfth most
ommon cancer in men” [1].
One of the most authoritative sources of information on can-
er epidemiology for the United States (US) is the Surveillance
pidemiology and End Results (SEER) program. SEER collects data
rom population-based registries covering 28% of the US popula-
ion. The most recent available cancer epidemiological information
ags 3 to 4 years behind the current year due to the time required
or data collection: 2014 SEER Cancer Statistics Review covers the
eriod between 1975 and 2011. Considering the US 2011 preva-
ence counts for invasive cancers, laryngeal carcinoma turned out
o be the 12th most common human malignancy in the adult age,
ith 98,482 cases [3]. It represented the 13th most common form
f cancer in males and came in 20th place for females [3].
Another source of valid epidemiologic information is the Euro-
ean Cancer Observatory, a project developed by the International
gency for Research on Cancer (IARC) that provides estimates
f cancer prevalence for the 24 major cancer types in 40 Euro-
ean countries [4]. Analyzing the estimated 2012 European 5-year
revalence, laryngeal carcinoma came in 11th place among human
alignancies (12th for men, and 21st for women) [4].
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879-7296/© 2015 Elsevier Masson SAS. All rights reserved.In order to provide an estimate of the contemporary cancer
burden, projections of new cancer cases are made using spatio-
temporal models. According to the American Cancer Society, which
every year estimates the numbers of new cancer cases that will
occur in the US, a total of 1,665,540 new cancer cases were projected
to occur in the United States in 2014 [5]. Laryngeal carcinoma, with
12,630 cases, would be the 21st human malignancy [5]. It would
be the 18th invasive cancer in men  (10,000 cases) and the 34th
in women [5]. A worldwide estimate of new cancer cases for 28
malignancies can be extrapolated from GLOBOCAN 2012 data [6]:
170,886 new laryngeal carcinoma cases are projected in 2015 (16th
human malignancy), 150,585 in men  (14th place), and 20,301 in
women (24th place).
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